On the regional experience of organizing specific immunoprophylaxis of respiratory syncytial viral infection in premature infants with palivizumab
https://doi.org/10.29039/1992-6499-2023-2-31-38
Abstract
The article presents the regional experience of organizing immunoprophylaxis of respiratory syncytial viral infection in premature infants, including those with bronchopulmonary dysplasia, with palivizumab is presented on the basis of Regional Children's Clinical Hospital named after. N.N. Silischeva. In the follow-up of children who received this drug for the observation period from 2019 to 2021, the following were noted: the absence of side effects and undesirable effects of the drug, high adherence of parents to treatment with palivizumab, the advantages of a centralized approach to organizing the prevention of RSV infection in premature infants from the high-risk group in the Astrakhan region.
About the Authors
M. V. Bogdanyants
Astrakhan State Medical University
Russian Federation
Russian Federation
M.V. Bogdanyants, Cand. Sci. (Med), Associate Professor of Department
Astrakhan
A. A. Dzhumagaziev
Astrakhan State Medical University
Russian Federation
Russian Federation
A.A. Dzhumagaziev, Dr. Sci. (Med), Professor, Professor of the Department
Astrakhana
A. Yu. Shmeleva
Astrakhan State Medical University
Russian Federation
Russian Federation
A.Y. Shmeleva, Cand. Sci. (Med), Assistant of Department
Astrakhana
T. D. Bezrukov
Astrakhan State Medical University
Russian Federation
Russian Federation
T.D. Bezrukov, Clinical Resident
Astrakhana
A. R. Anokhina
Astrakhan State Medical University
Russian Federation
Russian Federation
A.R. Anokhina, student
Astrakhana
N. A. Stepina
Ministry of Health of the Astrakhan Region
Russian Federation
Russian Federation
N.A. Stepina, Deputy
Astrakhana
E. A. Novikova
Regional Children's Clinical Hospital named after N.N. Silishcheva
Russian Federation
Russian Federation
E.A. Novikova, pediatrician, Head of the Day Hospital
Astrakhana
A. A. Demina
Ivanovo State Medical Academy
Russian Federation
Russian Federation
A.A. Demina, Clinical Resident
Ivanovo
References
1. Onalbaeva B. Zh., Baygazieva G. Zh., Zhubanysheva K. B., Ernazarkyzy A., Bakir A. M., Sarbas A. A., Shim V. R. The current state of the problem of premature babies born with extremely low body weight. Vestnik Ka-zakhskogo natsional'nogo meditsinskogo universiteta = Bulletin of the Kazakh National Medical University. 2020; (4): 212–218. (In Russ).
2. Dyumin I. I., Balakireva E. A. Nosological structure of pathology in preterm infants according to the Belgo-rod region. Rossiyskiy pediatricheskiy zhurnal= Russian Pediatric Journal 2020; 23 (1): 69. (In Russ).
3. Bronchopulmonary dysplasia: clinical recommendations. М.: 2020, 47 р. (In Russ).
4. Korsunskiy A. A., Ovsyannikov D. Yu., Degtyarev D. N., Yakovleva I. N., Degtyareva E. A., Bokeriya E. L., Keshishyan E. S., Shamsheva O. V., Pavlova E. S., Krsheminskaya I. V., Igityan Z. S., Markhuliya Kh. M., Balashova E. D., Alyamovskaya G. A., Mironyuk O. V., Potapova O. V. Immunoprophylaxis of respiratory syncytial viral infec-tion in children at risk of severe course: the first results of the implementation of the Moscow program. Pediatrich-eskaya farmakologiya= Pediatric Pharmacology 2012; 9 (3) : 22–31. (In Russ).
5. Alyamovskaya G. A., Keshishyan E. S. Experience in the use of palivizumab for the prevention of rhinosin-tial viral infection in premature infants with bronchopulmonary dysplasia. Topical issues of pediatrics. Vestnik RAMN= Bulletin of the Russian Academy of Medical Sciences. 2012; 12: 30–34. (In Russ).
6. Komkova G. N., Basova A. V. Medical and legal problems of nursing newborn babies with extremely low body weight. Rossiyskiy vestnik perinatologii i pediatrii= Russian Bulletin of Perinatology and Pediatrics 2020; 65 (2): 99–103. (In Russ).
7. Kulichenko T. V. Respiratory syncytial viral infection in children: new research. Pediatricheskaya farma-kologiya = Pediatric Pharmacology 2009; 6 (6): 70-76. (In Russ).
8. Lebedeva O. V., Polyanina E. Z., Kirilochev O. K., Kashirskaya E. I. Habilitation of preterm infants: the sig-nificance and prospects of development. Astrakhanskiy meditsinskiy zhurnal = Astrakhan Medical Journal 2019; 14 (1): 17–27. (In Russ).
9. Ovsyannikova D. Yu., Geppe N. A., Malakhova A. B., Degtyareva D. N. Bronchopulmonary dysplasia. Monografiya. Moscow; 2020. 198 р. (In Russ.).
10. Osmanov I.M., Mironova A.K., Zaplatnikov A.L. Modern approaches to improving the quality of medical care for premature babies in Moscow healthcare. Rossiyskiy vestnik perinatologii i pediatrii= Russian Bulletin of Peri-natology and Pediatrics. 2020; 65 (1): 5-10. (In Russ).
11. Volyanyuk E. V., Safina A. I. Immunoprophylaxis of respiratory syncytial virus infection in premature in-fants with bronchopulmonary dysplasia. Prakticheskaya meditsina = Practical medicine. 2017; 10 (111): 58–62.
12. Cobo T., Kacerovsky M., Jacobsson B. Risk factors for spontaneous preterm delivery. Int. J. Gynecol. Ob-stet. 2020; 150 (1): 17–23.
13. Salimah R. Walani.Global burden of preterm birth. International Journal of Gynecology and Obstet-rics.2020; 150 (1): 31–33. doi: 10.1002/ijgo.131955.
Review
For citations:
Bogdanyants M.V., Dzhumagaziev A.A., Shmeleva A.Yu., Bezrukov T.D., Anokhina A.R., Stepina N.A., Novikova E.A., Demina A.A. On the regional experience of organizing specific immunoprophylaxis of respiratory syncytial viral infection in premature infants with palivizumab. Astrakhan medical journal. 2023;18(2):31-38. (In Russ.) https://doi.org/10.29039/1992-6499-2023-2-31-38
Views:
291
Email this article 